Cognition Therapeutics, Inc.Cognition Therapeutics, Inc.Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc.

No trades
See on Supercharts

Price target

7.500.000.00%
The 6 analysts offering 1 year price forecasts for CGTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to CGTX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CGTX EPS for the last quarter is −0.18 USD despite the estimation of −0.24 USD. In the next quarter EPS is expected to reach −0.20 USD. Track more of Cognition Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Cognition Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Cognition Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, CGTX price target is 7.50 USD with a max estimate of 14.00 USD and a min estimate of 1.00 USD. Check if this forecast comes true in a year, meanwhile watch Cognition Therapeutics, Inc. stock price chart and keep track of the current situation with CGTX news and stock market news.
We've gathered opinions of 6 analysts rating CGTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.